Preliminary Results of the FASM Study, an On-Going Italian Active Pharmacovigilance Project.
Giorgia Teresa ManiscalcoVincenzo Brescia MorraCiro FlorioGiacomo LusGioacchino TedeschiMaddalena CianfraniRenato DocimoStefania MinielloFelice RomanoLeonardo SinisiDaniele L A SpitaleriGiuseppe LongoUgo TramaMaria Triassinull Fasm GroupCristina ScavoneAnnalisa CapuanoPublished in: Pharmaceuticals (Basel, Switzerland) (2020)
We believe that our results, together with those that will be presented at the end of the study, may bring new knowledge concerning the safety profile of DMTs and their proper use. This will provide the opportunity to draw new recommendations both for neurologists and patients.